Cord IgM antibody specific for human killer T cells: T lymphocytotoxic human fetal antibody (TLFA) recognizing maternal killer T cells proliferating in the presence of interleukin 2. 1982

Y Miyagawa, and A Komiyama, and T Akabane, and Y Uehara, and A Yano

T lymphocytotoxic human fetal antibody- (TLFA) containing cord IgM (TLFA IgM) was purified from cord blood. The proliferation of maternal mixed lymphocyte culture-(MLC) induced and long-term cultured T cells (LCT) specific to the paternal non-T cells in the presence of interleukin 2 (IL 2) was inhibited by treatment with the respective TLFA IgM plus complement (C). Sixty-six to 78% of Leu-2a-positive maternal LCT were stained with the respective TLFA IgM, as determined by anti-Leu antibodies and TLFA IgM double-staining. Moreover, TLFA IgM plus C treatment reduced the killer activity of the respective maternal LCT against the PHA-induced paternal target cells. Therefore, TLFA-positive killer T cells of maternal LCT belong to certain killer T cell subsets of Leu-2a-positive pan-killer T cells, and TLFA contains a potential antibody against maternal killer T cells.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females

Related Publications

Y Miyagawa, and A Komiyama, and T Akabane, and Y Uehara, and A Yano
April 1987, The American journal of nursing,
Y Miyagawa, and A Komiyama, and T Akabane, and Y Uehara, and A Yano
September 1982, Cellular immunology,
Y Miyagawa, and A Komiyama, and T Akabane, and Y Uehara, and A Yano
June 1985, European journal of immunology,
Y Miyagawa, and A Komiyama, and T Akabane, and Y Uehara, and A Yano
January 1983, Journal of the Reticuloendothelial Society,
Y Miyagawa, and A Komiyama, and T Akabane, and Y Uehara, and A Yano
June 1976, Journal of immunology (Baltimore, Md. : 1950),
Y Miyagawa, and A Komiyama, and T Akabane, and Y Uehara, and A Yano
October 1989, The Journal of experimental medicine,
Y Miyagawa, and A Komiyama, and T Akabane, and Y Uehara, and A Yano
November 1991, Japanese journal of cancer research : Gann,
Y Miyagawa, and A Komiyama, and T Akabane, and Y Uehara, and A Yano
December 2004, Developmental dynamics : an official publication of the American Association of Anatomists,
Y Miyagawa, and A Komiyama, and T Akabane, and Y Uehara, and A Yano
January 2004, Journal of endocrinological investigation,
Y Miyagawa, and A Komiyama, and T Akabane, and Y Uehara, and A Yano
October 1986, Immunology,
Copied contents to your clipboard!